| Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer M Ligorio, S Sil, J Malagon-Lopez, LT Nieman, S Misale, M Di Pilato, ... Cell 178 (1), 160-175. e27, 2019 | 480 | 2019 |
| CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment M Di Pilato, R Kfuri-Rubens, JN Pruessmann, AJ Ozga, M Messemaker, ... Cell 184 (17), 4512-4530. e22, 2021 | 308 | 2021 |
| The evolution of poxvirus vaccines L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Viruses 7 (4), 1726-1803, 2015 | 243 | 2015 |
| Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy M Di Pilato, EY Kim, BL Cadilha, JN Prüßmann, MN Nasrallah, ... Nature 570 (7759), 112-116, 2019 | 193 | 2019 |
| Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop F Marangoni, A Zhakyp, M Corsini, SN Geels, E Carrizosa, M Thelen, ... Cell 184 (15), 3998-4015. e19, 2021 | 140 | 2021 |
| T cells armed with CXC chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours S Lesch, V Blumenberg, S Stoiber, A Gottschlich, J Ogonek, BL Cadilha, ... Nature biomedical engineering 5 (11), 1246-1260, 2021 | 127 | 2021 |
| Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors BL Cadilha, MR Benmebarek, K Dorman, A Oner, T Lorenzini, H Obeck, ... Science advances 7 (24), eabi5781, 2021 | 90 | 2021 |
| Behavioural immune landscapes of inflammation G Crainiciuc, M Palomino-Segura, M Molina-Moreno, J Sicilia, ... Nature 601 (7893), 415-421, 2022 | 82 | 2022 |
| Dendritic cells as shepherds of T cell immunity in cancer MJ Pittet, M Di Pilato, C Garris, TR Mempel Immunity 56 (10), 2218-2230, 2023 | 62 | 2023 |
| Distinct roles of vaccinia virus NF-κB inhibitor proteins A52, B15, and K7 in the immune response M Di Pilato, E Mejías-Pérez, COS Sorzano, M Esteban Journal of virology 91 (13), 10.1128/jvi. 00575-17, 2017 | 54 | 2017 |
| CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection AJ Ozga, MT Chow, ME Lopes, RL Servis, M Di Pilato, P Dehio, J Lian, ... Immunity 55 (1), 82-97. e8, 2022 | 49 | 2022 |
| NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses M Di Pilato, E Mejías-Pérez, M Zonca, B Perdiguero, CE Gómez, ... Proceedings of the National Academy of Sciences 112 (11), E1333-E1342, 2015 | 41 | 2015 |
| Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production L Daszkiewicz, C Vázquez-Mateo, G Rackov, A Ballesteros-Tato, K Weber, ... Scientific reports 5 (1), 7691, 2015 | 41 | 2015 |
| Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine … B Perdiguero, CE Gómez, M Di Pilato, COS Sorzano, J Delaloye, T Roger, ... PloS one 8 (9), e74831, 2013 | 38 | 2013 |
| New vaccinia virus promoter as a potential candidate for future vaccines M Di Pilato, E Mejías-Pérez, CE Gomez, B Perdiguero, COS Sorzano, ... Journal of General Virology 94 (12), 2771-2776, 2013 | 33 | 2013 |
| HIV-1 balances the fitness costs and benefits of disrupting the host cell actin cytoskeleton early after mucosal transmission SM Usmani, TT Murooka, M Deruaz, WH Koh, RR Sharaf, M Di Pilato, ... Cell host & microbe 25 (1), 73-86. e5, 2019 | 25 | 2019 |
| Modification of promoter spacer length in vaccinia virus as a strategy to control the antigen expression M Di Pilato, L Sanchez-Sampedro, E Mejías-Pérez, COS Sorzano, ... Journal of General Virology 96 (8), 2360-2371, 2015 | 19 | 2015 |
| The evolution of poxvirus vaccines. Viruses 7: 1726–1803 L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Article CAS PubMed PubMed Central, 2015 | 16 | 2015 |
| Neutrophil subtypes shape HIV-specific CD8 T-cell responses after vaccinia virus infection M Di Pilato, M Palomino-Segura, E Mejías-Pérez, CE Gómez, ... npj Vaccines 6 (1), 52, 2021 | 9 | 2021 |
| Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer M Di Pilato, Y Gao, Y Sun, A Fu, C Grass, T Seeholzer, R Feederle, I Mazo, ... Journal of Immunotherapy and Precision Oncology 6 (2), 61-73, 2023 | 6 | 2023 |
